DrugPatentWatch Database Preview
Emd Serono Company Profile
What is the competitive landscape for EMD SERONO, and when can generic versions of EMD SERONO drugs launch?
EMD SERONO has thirteen approved drugs.
There are five US patents protecting EMD SERONO drugs.
There are one hundred and two patent family members on EMD SERONO drugs in thirty-nine countries and twelve supplementary protection certificates in six countries.
Summary for Emd Serono
| International Patents: | 102 |
| US Patents: | 5 |
| Tradenames: | 13 |
| Ingredients: | 8 |
| NDAs: | 13 |
Drugs and US Patents for Emd Serono
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021765-001 | Mar 25, 2004 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Emd Serono | GONAL-F RFF REDI-JECT | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021684-002 | May 25, 2004 | RX | Yes | Yes | 7,741,268 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Emd Serono | SEROSTIM | somatropin recombinant | INJECTABLE;INJECTION | 020604-001 | Aug 23, 1996 | BX | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021765-003 | Mar 25, 2004 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Emd Serono
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Emd Serono | GONAL-F RFF REDI-JECT | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 021684-003 | May 25, 2004 | 5,767,067 | ➤ Try a Free Trial |
| Emd Serono | GONAL-F | follitropin alfa/beta | INJECTABLE;SUBCUTANEOUS | 020378-001 | Sep 29, 1997 | 4,589,402 | ➤ Try a Free Trial |
| Emd Serono | SAIZEN | somatropin recombinant | INJECTABLE;INJECTION | 019764-003 | Aug 29, 2000 | 5,898,030 | ➤ Try a Free Trial |
| Emd Serono | SEROSTIM | somatropin recombinant | INJECTABLE;INJECTION | 020604-004 | Sep 6, 2001 | 5,898,030 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Emd Serono Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2002512975 | ➤ Try a Free Trial |
| Cyprus | 1111291 | ➤ Try a Free Trial |
| Malaysia | 135913 | ➤ Try a Free Trial |
| Israel | 140984 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Emd Serono Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2010000011 | Germany | ➤ Try a Free Trial | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125 |
| C/GB10/022 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTERED: UK EU/1/09/609/001 20100125; UK EU/1/09/609/002 20100125 |
| 90029 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: CETRORELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZUUR ADDITIEZOUT, IN HET BIJZONDER CETRORELIX ACETAAT; REGISTRATION NO/DATE: EU/1/99/100/001-003 19990413 |
| 00440 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125; FORMER OWNER: N.V. ORGANON, NL |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
